Wild-type huntingtin protects neurons from excitotoxicity

Journal of Neurochemistry

Volumn 96, Issue 4, 2006, Pages 1121-1129

  Leavitt, Blair R ^a,b   Van Raamsdonk, Jeremy M ^a   Shehadeh, Jacqueline ^a   Fernandes, Herman ^a   Murphy, Zoe ^a   Graham, Rona K ^a   Wellington, Cheryl L ^a   Raymond, Lynn A ^a,b   Hayden, Michael R ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Excitotoxicity; Huntington; Huntington's disease; Neurodegeneration; Neuroprotection

Indexed keywords

CAFFEINE; CASPASE 3; HUNTINGTIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; QUINOLINIC ACID; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; YEAST ARTIFICIAL CHROMOSOME;

ANIMALS; APOPTOSIS; CAFFEINE; CASPASE 3; CASPASES; CHROMOSOMES, ARTIFICIAL, YEAST; HUMANS; MICE; MICE, TRANSGENIC; N-METHYLASPARTATE; NERVE TISSUE PROTEINS; NEURONS; NEUROTOXINS; NUCLEAR PROTEINS; RECOMBINANT PROTEINS; STAUROSPORINE;

ANIMALIA; MUS MUSCULUS;

EID: 33645100553     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03605.x     Document Type: Article

References (49)

1. Auerbach W. Hurlbert MS. Hilditch-Maguire P. Wadghiri YZ. Wheeler VC. Cohen SI. Joyner AL. MacDonald ME. Turnbull DH. 2001 The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin HumMolGenet 10 2515 2523
2. Beal MF. 1992 Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? AnnNeurol 31 119 130
3. Beal MF. Kowall NW. Ellison DW. Mazurek MF. SwartZ KJ. Martin JB. 1986 Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 168 171
4. Cattaneo E. Rigamonti D. Goffredo D. Zuccato C. Squitieri F. Sipione S. 2001 Loss of normal huntingtin function: new developments in Huntington's disease research Trends Neurosci 24 182 188
5. Cattaneo E. Rigamonti D. Zuccato C. 2002 The enigma of Huntington's disease SciAm 287 92 97
6. Cepeda C. Ariano MA. Calvert CR. Flores-Hernandez J. Chandler SH. Leavitt BR. Hayden MR. Levine MS. 2001 NMDA receptor function in mouse models of Huntington disease JNeurosciRes 66 525 539
7. Cha JH. 2000 Transcriptional dysregulation in Huntington's disease Trends Neurosci 23 387 392
8. Chan EY. Luthi-Carter R. Strand A. et al. 2002 Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease HumMolGenet 11 1939 1951
9. Chen N. Luo T. Wellington C. Metzler M. McCutcheon K. Hayden MR. Raymond LA. 1999 Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin JNeurochem 72 1890 1898
10. Coyle JT. Ferkany JW. Zaczek R. 1983 Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease NeurobehavToxicolTeratol 5 617 624
11. DiFiglia M. Sapp E. Chase KO. Davies SW. Bates GP. Vonsattel JP. Aronin N. 1997 Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1990 1993
12. Dragatsis I. Levine MS. Zeitlin S. 2000 Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice NatGenet 26 300 306
13. Duyao MP. Auerbach AB. Ryan A. Persichetti F. Barnes GT. McNeil SM. Ge P. Vonsattel JP. Gusella JF. Joyner AL. 1995 Inactivation of the mouse Huntington's disease gene homolog Hdh Science 269 407 410
14. Ellerby LM. Andrusiak RL. Wellington CL. et al. 1999 Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity JBiolChem 274 8730 8736
15. Friedlander RM. Brown RH. Gagliardini V. Wang J. Yuan J. 1997 Inhibition of ICE slows ALS in mice Nature 388 31
16. Fusco FR. Zuccato C. Tartari M. Martorana A. De March Z. Giampa C. Cattaneo E. Bernardi G. 2003 Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain EurJNeurosci 18 1093 1102
17. Gervais FG. Xu D. Robertson GS. et al. 1999 Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation Cell 97 395 406
18. Goffredo D. Rigamonti D. Tartari M. De Micheli A. Verderio C. Matteoli M. Zuccato C. Cattaneo E. 2002 Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons JBiolChem 277 39 594 39 598
19. Goldberg YP. Nicholson DW. Rasper DM. et al. 1996 Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract [see comments] NatGenet 13 442 449
20. Hansson OAPN. Leist M. Nicotera P. Castilho RF. Brundin P. 1999 Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity ProcNatl AcadSciUSA 96 8727 8732
21. Ho LW. Brown R. Maxwell M. Wyttenbach A. Rubinsztein DC. 2001 Wild type Huntingtin reduces the cellular toxicity of mutant Huntingtin in mammalian cell models of Huntington's disease JMedGenet 38 450 452
22. Hodgson JG. Smith DJ. McCutcheon K. et al. 1996 Human huntingtin derived from YAC transgenes compensates for loss of murine huntingtin by rescue of the embryonic lethal phenotype HumMolGenet 5 1875 1885
23. Hodgson JG. Agopyan N. Gutekunst CA. et al. 1999 A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration Neuron 23 181 192
24. Huntington's Disease Collaborative Research Group 1993 A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group [see comments] Cell 72 971 983
25. Jana NR. Zemskov EA. Wang G. Nukina N. 2001 Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release HumMolGenet 10 1049 1059
26. Leavitt BR. Guttman JA. Hodgson JG. Kimel GH. Singaraja R. Vogl AW. Hayden MR. 2001 Wild-type huntingtin reduces the cellular toxicity of mutant huntingtin in vivo AmJHumGenet 68 313 324
27. Levine MS. Klapstein GJ. Koppel A. et al. 1999 Enhanced sensitivity to N-methyl- d -aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease JNeurosciRes 58 515 532
28. Li SH. Lam S. Cheng AL. Li XJ. 2000 Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis HumMolGenet 9 2859 2867
29. Luthi-Carter R. Strand A. Peters NL. et al. 2000 Decreased expression of striatal signaling genes in a mouse model of Huntington's disease Human MolGenet 9 1259 1271
30. MacDonald ME. Gusella JF. 1996 Huntington's disease: translating a CAG repeat into a pathogenic mechanism CurrOpinNeurobiol 6 638 643
31. Martindale D. Hackam A. Wieczorek A. et al. 1998 Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates NatGenet 18 150 154
32. McGeer EG. McGeer PL. 1976 Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids Nature 263 517 519
33. Mende-Mueller LM. Toneff T. Hwang S-R. Chesselet M-F. Hook VYH. 2001 Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum JNeurosci 21 1830 1837
34. Nasir J. Floresco SB. O'Kusky JR. Diewert VM. Richman JM. Zeisler J. Borowski A. Marth JD. Phillips AG. Hayden MR. 1995 Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes Cell 81 811 823
35. O'Kusky JR. Nasir J. Cicchetti F. Parent A. Hayden MR. 1999 Neuronal degeneration in the basal ganglia and loss of pallido-subthalamic synapses in mice with targeted disruption of the Huntington's disease gene Brain Res 818 468 479
36. Ona VO. Li M. Vonsattel JP. et al. 1999 Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease [see comments] Nature 399 263 267
37. Rigamonti D. Bauer JH. De Fraja C. et al. 2000 Wild-type huntingtin protects from apoptosis upstream of caspase-3 JNeurosci 20 3705 3713
38. Rigamonti D. Sipione S. Goffredo D. Zuccato C. Fossale E. Cattaneo E. 2001 Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing JBiolChem 276 14 545 14 548
39. Sanchez I. Xu CJ. Juo P. Kakizaka A. Blenis J. Yuan J. 1999 Caspase-8 is required for cell death induced by expanded polyglutamine repeats [see comments] Neuron 22 623 633
40. Sharp AH. Loev SJ. Schilling G. Li SH. Li XJ. Bao J. Wagster MV. Kotzuk JA. Steiner JP. Lo A. 1995 Widespread expression of Huntington's disease gene (IT15) protein product Neuron 14 1065 1074
41. Sugars KL. Rubinsztein DC. 2003 Transcriptional abnormalities in Huntington disease Trends Genet 19 233 238
42. Wellington CL. Hayden MR. 1997 Of molecular interactions, mice and mechanisms: new insights into Huntington's disease CurrOpinNeurol 10 291 298
43. Wellington CL. Ellerby LM. Hackam AS. et al. 1998 Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract JBiolChem 273 9158 9167
44. Wellington CL. Singaraja R. Ellerby L. et al. 2000 Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells JBiolChem 275 19 831 19 838
45. Wellington CL. Ellerby LM. Gutekunst CA. et al. 2002 Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease JNeurosci 22 7862 7872
46. Wyttenbach A. Carmichael J. Swartz J. Furlong RA. Narain Y. Rankin J. Rubinsztein DC. 2000 Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease ProcNatl AcadSciUSA 97 2898 2903
47. Zeitlin S. Liu JP. Chapman DL. Papaioannou VE. Efstratiadis A. 1995 Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue NatGenet 11 155 163
48. Zeron MM. Chen N. Moshaver A. Lee AT. Wellington CL. Hayden MR. Raymond LA. 2001 Mutant huntingtin enhances excitotoxic cell death MolCellNeurosci 17 41 53
49. Zeron MM. Hansson O. Chen N. Wellington CL. Leavitt BR. Brundin P. Hayden MR. Raymond LA. 2002 Increased sensitivity to N-methyl- d -aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease Neuron 14 849 860